The purpose of the Administration Core is to support the translational research objectives of the UCLA SPORE in Prostate Cancer by serving as the organizational hub. The Core is responsible for the oversight of our SPORE by providing scientific leadership and administration for the proposed translational research projects, shared core resources. Developmental Research (DRP) and Career Development Programs (CDP). The overall Specific Aims are: 1) Organizational leadership for successful SPORE conduct;2) Oversight and administrative support for daily SPORE activities;3) Scientific management of the SPORE, including scientific review of projects and cores to ensure scientific goals are met;4) Administration of the DRP and CDP;5) Responsibility for maintaining fiscal and budgetary functions;6) Organization and conduct of regular SPORE meetings and seminars. Including the Annual UCLA SPORE in Prostate Cancer Symposium, quarterly investigator meetings, attendance at the NCI Translational Science meeting and relevant NIH/NCI workshops;7) Compliance with all UCLA, NCI, and Federal regulations and requirements including appropriate animal subject approval maintenance, appropriate human subject approval maintenance, and minority inclusion policy monitoring;8) A Data/Resource Sharing Plan implemented by project and core investigators;9) Liaison service for SPORE investigators, collaborators, and committee members, including the External Advisory Board (EAB), Internal Advisory Board (IAB), Executive Committee and Patient Advocacy Group, and responsibility for communication and consultation with the NCI-TRP program officer and staff;10) Implement and monitor recommendations of the External Advisory Committee, Internal Advisory Board, Executive Committee, CDP and DRP committees within the SPORE. The Administration Core is led by Robert Reiter, MD, the SPORE principal investigator, who oversees all SPORE activities. The Core's co-director is Owen Witte, MD. The Administration Core also includes expert personnel in general university operations, grants administration, financial management, computer network support and general administrative duties.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
5P50CA092131-12
Application #
8760362
Study Section
Special Emphasis Panel (ZCA1-RPRB-M)
Project Start
Project End
Budget Start
2014-09-01
Budget End
2015-08-31
Support Year
12
Fiscal Year
2014
Total Cost
$179,159
Indirect Cost
$75,313
Name
University of California Los Angeles
Department
Type
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Henning, Susanne M; Wang, Piwen; Said, Jonathan W et al. (2015) Randomized clinical trial of brewed green and black tea in men with prostate cancer prior to prostatectomy. Prostate 75:550-9
Apostolova, Liana G; Di, Li Jie; Duffy, Erin L et al. (2014) Risk factors for behavioral abnormalities in mild cognitive impairment and mild Alzheimer's disease. Dement Geriatr Cogn Disord 37:315-26
Li, Z; Tseng, C-H; Li, Q et al. (2014) Clinical efficacy of a medically supervised outpatient high-protein, low-calorie diet program is equivalent in prediabetic, diabetic and normoglycemic obese patients. Nutr Diabetes 4:e105
Lin, Millicent; Chen, Jie-Fu; Lu, Yi-Tsung et al. (2014) Nanostructure embedded microchips for detection, isolation, and characterization of circulating tumor cells. Acc Chem Res 47:2941-50
Keto, Christopher J; Aronson, William J; Terris, Martha K et al. (2014) Detectable prostate-specific antigen Nadir during androgen-deprivation therapy predicts adverse prostate cancer-specific outcomes: results from the SEARCH database. Eur Urol 65:620-7
Hsi, Eric D; Said, Jonathan; Macon, William R et al. (2014) Diagnostic accuracy of a defined immunophenotypic and molecular genetic approach for peripheral T/NK-cell lymphomas. A North American PTCL study group project. Am J Surg Pathol 38:768-75
Wu, Anna M (2014) Engineered antibodies for molecular imaging of cancer. Methods 65:139-47
Garcia, Alejandro J; Ruscetti, Marcus; Arenzana, Teresita L et al. (2014) Pten null prostate epithelium promotes localized myeloid-derived suppressor cell expansion and immune suppression during tumor initiation and progression. Mol Cell Biol 34:2017-28
Chamie, Karim; Sonn, Geoffrey A; Finley, David S et al. (2014) The role of magnetic resonance imaging in delineating clinically significant prostate cancer. Urology 83:369-75
Galet, Colette; Gollapudi, Kiran; Stepanian, Sevan et al. (2014) Effect of a low-fat fish oil diet on proinflammatory eicosanoids and cell-cycle progression score in men undergoing radical prostatectomy. Cancer Prev Res (Phila) 7:97-104

Showing the most recent 10 out of 189 publications